Syndax Pharmaceuticals Inc
SNDX
Market Cap$1.18B
Close$
$-2.08
118.9% downside
Current Fair Value
118.9% downsideOvervalued by 118.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.18 Billion |
|---|---|
| Enterprise Value | $1.37 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-3.73 |
| Beta | 1.28 |
| Outstanding Shares | 85,791,198 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -3.7 |
|---|---|
| PEG | -5.73 |
| Price to Sales | - |
| Price to Book Ratio | 3.67 |
| Enterprise Value to Revenue | 83.03 |
| Enterprise Value to EBIT | -4.35 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.25 |
| Debt to Equity | 1.2 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Syndax Pharmaceuticals Inc
CEO: Arlene Morris